As an intellectual property attorney with over a decade of experience as a patent practitioner in the fields of small molecule pharmaceuticals, medical devices, and life sciences, Ashley focuses her practice on domestic and international patent prosecution, as well as intellectual property due diligence, counseling, and portfolio management, developing robust legal strategies in complex technological areas.
Prior to joining the firm, Ashley worked as an intellectual property associate in Morrison & Foerster LLP’s chemistry practice group.
Ashley has also worked as an associate at an IP boutique law firm, where she prepared and prosecuted U.S. and international patents and counseled clients regarding freedom-to-operate and due diligence concerns. While attending law school, Ashley was a member of Law Review and served as the Intellectual Property Law Society president. Ashley also served as a patent agent for the Innovations Department at the State University of New York Research Foundation and other IP boutique firms, a summer associate at Lerner David, and a legal intern in the Civil Division of the U.S. Attorney’s Office for the Northern District of New York.
At the University of Notre Dame, Ashley received an M.S. in organic chemistry and an M.S. in patent law. While at the University of Notre Dame, Ashley served as a computational organic chemistry and drug design graduate researcher studying the molecular basis for specificity in protein-protein interactions through observing the molecular logic of cell-surface receptors, focusing on proteins implicated in human disease, in collaboration with the Dana Farber Cancer Institute of Harvard University Medical School.
Ashley received national recognition from the American Intellectual Property Law Association via the Robert C. Watson Award (2018-2019) and from the American Chemical Society via the Philadelphia Section Scholastic Achievement Award (2010). She is also an accomplished publisher, served as a judge for several legal competitions, and moderated several interactive continuing legal education courses at the New Jersey State Bar Association Annual Meeting in 2022 and before the American Bar Association in 2023.
IP Portfolio Development
Analyses of Competitor & Target IP
Chemistry & Materials
Pharmaceuticals
Medical devices
Life sciences
Nanotechnology
Semiconductor Technologies
Electrochemical Engineering
Green Energy Technologies
B.S. Chemistry (Honors Program), Minor in Physics, Arcadia University
M.S. Organic Chemistry, University of Notre Dame
M.S. Patent Law, University of Notre Dame
J.D. Albany Law School
New Jersey State Bar
United States District Court for the District of New Jersey
New York State Bar
U.S. Patent Bar
Robert C. Watson Award, American Intellectual Property Law Association (AIPLA) (2018-2019)
The Philadelphia Section Achievement Award, American Chemical Society (ACS) (2010)
Annual Award (Chemistry), Arcadia University (2010)
American Bar Association Young Lawyers Division (2019-Present)
Program Awards Committee, American Inns of Court (2021-Present)
A. Sperbeck, et al., Under lock and key – Private sales may not qualify as public disclosure, MoFo Life Sci. Blog (Sept. 19, 2024).
Ashley Sperbeck, Weight-Loss Wonder Drug Faces Legal Disputes, American Bar Association Landslide®, Vol. 17, No. 1 (Sept. 16, 2024).
A. Sperbeck, et al., Federal Circuit Wades into Article III Standing in Patent Cases Once Again, MoFo Client Alert (Jun. 27, 2024).
A. Sperbeck, et al., The Future of the Pharmaceutical Industry’s Hold on Intellectual Property Rights, American Bar Association Health eSource (May 29, 2024).
A. Sperbeck, et al., Federal Court Invalidates Dosing Patent Based on Clinical Trials Disclosure, MoFo Life Sci. Blog (Jun. 7, 2024).
A. Sperbeck, et al., Patent Prosecution Strategies to Avoid Pitfalls in Post-Grant Proceedings, MoFo Life Sci. Blog (Nov. 14, 2023).
Ashley Sperbeck, How Intellectual Property Regimes and Innovative Infrastructure Promote Growth of Africa’s Technological Market, in Technological Leapfrogging and Innovation in Africa: Digital Transformation and Opportunity for the Next Growth Continent 245 (Ethne Swartz et al. eds.) (Oct. 17, 2023).
A. Sperbeck, et al., Obviousness in Drug Combinations – Unexpected Results vs. Unexpected Mechanisms of Action, MoFo Life Sci. Blog (Jul. 20, 2023).
M. Cometti, et al., From Markets to Tech: Governmental Initiatives, Solutions, and Responses to Food Insecurity, 19(3) J. Pub. Aff. e1860 (2019).
Ashley Sperbeck, Effect of the Regulatory Accountability Act of 2017 on Inter Partes Review: A Look at Telebrands Corp., v. Tinnus Enters., LLC, 82 Alb. L. Rev. 349 (2018/2019).
Ashley Sperbeck, A Mathematical Solution to the Sine of Madness that is Pharmaceutical Compulsory Licensing Under the TRIPS Agreement and the Doha Declaration, 21 Marq. Intell. Prop. L. Rev. (Winter 2018).
Hongmei Li, et al., A Concise and Atom-Economical Suzuki–Miyaura Coupling Reaction Using Unactivated Trialkyl- and Triarylboranes with Aryl Halides, 17 Organic Letters 3616 (2015).
Hongmei Li, et al., Cross-Coupling of Unactivated Trialkyl(aryl)boranes with Aryl Halides, 17 SYNFACTS 1089 (2015).